[Adenosine triphosphoric acid in the treatment of newborn infants of diabetic mothers].
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D001238:Asphyxia Neonatorum / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007773:Lactates / Q000097:blood; D008431:Maternal-Fetal Exchange; D010101:Oxygen Consumption / Q000187:drug effects; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D011773:Pyruvates / Q000097:blood; D013831:Thiamine / Q000627:therapeutic use; D008063:Thioctic Acid / Q000627:therapeutic use
D007773:Lactates; D011773:Pyruvates; D008063:Thioctic Acid; D000255:Adenosine Triphosphate; D013831:Thiamine
Die Adenosintriphosphorsäure bei der Behandlung Neugeborener von diabetischen Müttern.